Your browser doesn't support javascript.
loading
The central serotonin2B receptor as a new pharmacological target for the treatment of dopamine-related neuropsychiatric disorders: Rationale and current status of research.
Devroye, Céline; Cathala, Adeline; Piazza, Pier Vincenzo; Spampinato, Umberto.
Afiliação
  • Devroye C; Inserm U1215, Neurocentre Magendie, Physiopathology of Addiction and Traumatic Memories Group, Bordeaux F-33000, France; Université de Bordeaux, Bordeaux F-33000, France.
  • Cathala A; Inserm U1215, Neurocentre Magendie, Physiopathology of Addiction and Traumatic Memories Group, Bordeaux F-33000, France; Université de Bordeaux, Bordeaux F-33000, France.
  • Piazza PV; Inserm U1215, Neurocentre Magendie, Physiopathology of Addiction and Traumatic Memories Group, Bordeaux F-33000, France; Université de Bordeaux, Bordeaux F-33000, France.
  • Spampinato U; Inserm U1215, Neurocentre Magendie, Physiopathology of Addiction and Traumatic Memories Group, Bordeaux F-33000, France; Université de Bordeaux, Bordeaux F-33000, France. Electronic address: umberto.spampinato@inserm.fr.
Pharmacol Ther ; 181: 143-155, 2018 01.
Article em En | MEDLINE | ID: mdl-28757154
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Esquizofrenia / Transtornos Relacionados ao Uso de Substâncias / Receptor 5-HT2B de Serotonina / Antagonistas do Receptor 5-HT2 de Serotonina / Neurônios Dopaminérgicos Idioma: En Ano de publicação: 2018 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Esquizofrenia / Transtornos Relacionados ao Uso de Substâncias / Receptor 5-HT2B de Serotonina / Antagonistas do Receptor 5-HT2 de Serotonina / Neurônios Dopaminérgicos Idioma: En Ano de publicação: 2018 Tipo de documento: Article